Ionizing radiation modulates the surface expression of human leukocyte antigen-G in a human melanoma cell line

Human Immunology

Volumn 70, Issue 12, 2009, Pages 1010-1015

  Michelin, Severino ^a   Gallegos, Cristina E ^a   Dubner, Diana ^a   Favier, Benoit ^b   Carosella, Edgardo D ^b  

^a Nuclear Regulatory Authority   (Argentina)

^b SAINT LOUIS HOSPITAL   (France)

Author keywords

Radiation; HLA G; Immune system; Immunotolerance; Melanoma

Indexed keywords

CD94 ANTIGEN; HLA ANTIGEN CLASS 1; HLA E ANTIGEN; HLA G ANTIGEN; HLA G1 ANTIGEN; HLA I ANTIGEN; MEMBRANE ENZYME; NATURAL KILLER CELL RECEPTOR NKG2A; SOLUBLE HLA G1 ANTIGEN; UNCLASSIFIED DRUG;

ARTICLE; CELL CYCLE ARREST; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL MEMBRANE; CELL SURFACE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CULTURE MEDIUM; DOWN REGULATION; FLOW CYTOMETRY; GAMMA IRRADIATION; HUMAN; HUMAN CELL; IONIZING RADIATION; MELANOMA CELL; MULTINUCLEAR CELL; POLYPLOIDY; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN DEGRADATION; RADIATION DOSE FRACTIONATION; RADIATION EXPOSURE; TUMOR ESCAPE;

CELL CYCLE; CELL LINE, TUMOR; GAMMA RAYS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA ANTIGENS; HUMANS; MELANOMA; SKIN NEOPLASMS;

EID: 70449534075     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humimm.2009.07.030     Document Type: Article

References (59)

1. Delaney G., Jacob S., Featherstone C., and Barton M. The role of radiotherapy in cancer treatment: estimating optimal utilization from a review of evidence-based clinical guidelines. Cancer 104 (2005) 1129-1137
2. Bourguignon M.H., Gisone P.A., Perez M.R., Michelin S., Dubner D., Di Giorgio M., et al. Genetic and epigenetic features in radiation sensitivity Part I: cell signalling in radiation response. Eur J Nucl Med Mol Imaging 32 (2005) 229-246
3. Bourguignon M.H., Gisone P.A., Perez M.R., Michelin S., Dubner D., Di Giorgio M., et al. Genetic and epigenetic features in radiation sensitivity. Part II: implications for clinical practice and radiation protection. Eur J Nucl Med Mol Imaging 32 (2005) 351-368
4. Koenig K.L., Goans R.E., Hatchett R.J., Mettler Jr. F.A., Schumacher T.A., Noji E.K., et al. Medical treatment of radiological casualties: current concepts. Ann Emerg Med 45 (2005) 643-652
5. Pandey R., Shankar B.S., Sharma D., and Sainis K.B. Low dose radiation induced immunomodulation: effect on macrophages and CD8+ T cells. Int J Radiat Biol 81 (2005) 801-812
6. Friedman E.J. Immune modulation by ionizing radiation and its implications for cancer immunotherapy. Curr Pharm Des 8 (2002) 1765-1780
7. Nikitina E.Y., and Gabrilovich D.I. Combination of gamma-irradiation and dendritic cell administration induces a potent antitumor response in tumor-bearing mice: approach to treatment of advanced stage cancer. Int J Cancer 94 (2001) 825-833
8. Favier B., LeMaoult J., Rouas-Freiss N., Moreau P., Menier C., and Carosella E.D. Research on HLA-G: an update. Tissue Antigens 69 (2007) 207-211
9. Kovats S., Main E.K., Librach C., Stubblebine M., Fisher S.J., and DeMars R. A class I antigen, HLA-G, expressed in human trophoblasts. Science 248 (1990) 220-223
10. Crisa L., McMaster M.T., Ishii J.K., Fisher S.J., and Salomon D.R. Identification of a thymic epithelial cell subset sharing expression of the class Ib HLA-G molecule with fetal trophoblasts. J Exp Med 186 (1997) 289-298
11. Le Discorde M., Moreau P., Sabatier P., Legeais J.M., and Carosella E.D. Expression of HLA-G in human cornea, an immune-privileged tissue. Hum Immunol 64 (2003) 1039-1044
12. Cirulli V., Zalatan J., McMaster M., Prinsen R., Salomon D.R., Ricordi C., et al. The class I HLA repertoire of pancreatic islets comprises the nonclassical class Ib antigen HLA-G. Diabetes 55 (2006) 1214-1222
13. Menier C., Rabreau M., Challier J.C., Le Discorde M., Carosella E.D., and Rouas-Freiss N. Erythroblasts secrete the nonclassical HLA-G molecule from primitive to definitive hematopoiesis. Blood 104 (2004) 3153-3160
14. Carosella E.D., Moreau P., Le Maoult J., Le Discorde M., Dausset J., and Rouas-Freiss N. HLA-G molecules: from maternal-fetal tolerance to tissue acceptance. Adv Immunol 81 (2003) 199-252
15. Rouas-Freiss N., Moreau P., Menier C., LeMaoult J., and Carosella E.D. Expression of tolerogenic HLA-G molecules in cancer prevents antitumor responses. Semin Cancer Biol 17 (2007) 413-421
16. LeMaoult J., Rouas-Freiss N., and Carosella E.D. Immuno-tolerogenic functions of HLA-G: relevance in transplantation and oncology. Autoimmun Rev 4 (2005) 503-509
17. Rouas-Freiss N., Moreau P., Ferrone S., and Carosella E.D. HLA-G proteins in cancer: do they provide tumor cells with an escape mechanism?. Cancer Res 65 (2005) 10139-10144
18. Seliger B., Abken H., and Ferrone S. HLA-G and MIC expression in tumors and their role in anti-tumor immunity. Trends Immunol 24 (2003) 82-87
19. Le Gal F.A., Riteau B., Sedlik C., Khalil-Daher I., Menier C., Dausset J., et al. HLA-G-mediated inhibition of antigen-specific cytotoxic T lymphocytes. Int Immunol 11 (1999) 1351-1356
20. Rebmann V., Regel J., Stolke D., and Grosse-Wilde H. Secretion of sHLA-G molecules in malignancies. Semin Cancer Biol 13 (2003) 371-377
21. Paul P., Rouas-Freiss N., Khalil-Daher I., Moreau P., Riteau B., Le Gal F.A., et al. HLA-G expression in melanoma: a way for tumor cells to escape from immunosurveillance. Proc Natl Acad Sci USA 95 (1998) 4510-4515
22. Paul P., Cabestre F.A., Le Gal F.A., Khalil-Daher I., Le Danff C., Schmid M., et al. Heterogeneity of HLA-G gene transcription and protein expression in malignant melanoma biopsies. Cancer Res 59 (1999) 1954-1960
23. Boon T., Coulie P.G., Van den Eynde B.J., and van der B.P. Human T cell responses against melanoma. Annu Rev Immunol 24 (2006) 175-208
24. Adrian C.F., Moreau P., Riteau B., Ibrahim E.C., Le Danff C., Dausset J., et al. HLA-G expression in human melanoma cells: protection from NK cytolysis. J Reprod Immunol 43 (1999) 183-193
25. Rouas-Freiss N., Bruel S., Menier C., Marcou C., Moreau P., and Carosella E.D. Switch of HLA-G alternative splicing in a melanoma cell line causes loss of HLA-G1 expression and sensitivity to NK lysis. Int J Cancer 117 (2005) 114-122
26. Jemal A., Tiwari R.C., Murray T., Ghafoor A., Samuels A., Ward E., et al. Cancer statistics, 2004. CA Cancer J Clin 54 (2004) 8-29
27. Stahl S., Bar-Meir E., Friedman E., Regev E., Orenstein A., and Winkler E. Genetics in melanoma. Isr Med Assoc J 6 (2004) 774-777
28. Chung E.S., Sabel M.S., and Sondak V.K. Current state of treatment for primary cutaneous melanoma. Clin Exp Med 4 (2004) 65-77
29. Ballo M.T., and Ang K.K. Radiotherapy for cutaneous malignant melanoma: rationale and indications. Oncology (Williston Park) 18 (2004) 99-107
30. Lugade A.A., Moran J.P., Gerber S.A., Rose R.C., Frelinger J.G., and Lord E.M. Local radiation therapy of B16 melanoma tumors increases the generation of tumor antigen-specific effector cells that traffic to the tumor. J Immunol 174 (2005) 7516-7523
31. Mortier L., Mirabel X., Modiano P., Patenotre P., Piette F., and Lartigau E. [Interstitial brachytherapy in management of primary cutaneous melanoma: 4 cases]. Ann Dermatol Venereol 133 (2006) 153-156
32. Marucci L., Lane A.M., Li W., Egan K.M., Gragoudas E.S., Adams J.A., et al. Conservation treatment of the eye: Conformal proton reirradiation for recurrent uveal melanoma. Int J Radiat Oncol Biol Phys 64 (2006) 1018-1022
33. Gonzalez S.J., Bonomi M.R., Santa Cruz G.A., Blaumann H.R., Calzetta Larrieu O.A., Menendez P., et al. First BNCT treatment of a skin melanoma in Argentina: dosimetric analysis and clinical outcome. Appl Radiat Isot 61 (2004) 1101-1105
34. Gisone P., Robello E., Sanjurjo J., Dubner D., Perez M.R., Michelin S., et al. Reactive species and apoptosis of neural precursor cells after gamma-irradiation. Neurotoxicology 27 (2006) 253-259
35. Huang H., Fletcher L., Beeharry N., Daniel R., Kao G., Yen T.J., et al. Abnormal cytokinesis after X-irradiation in tumor cells that override the G2 DNA damage checkpoint. Cancer Res 68 (2008) 3724-3732
36. Topcu-Tarladacalisir Y., Kanter M., and Uzal M.C. Role of L-: carnitine in the prevention of seminiferous tubules damage induced by gamma radiation: a light and electron microscopic study. Arch Toxicol 83 (2009) 735-746
37. Bansal M.R., Kaul A., Tewari M., and Nehru B. Spermatogenesis and epididymal sperm after scrotal gamma irradiation in adult rats. Reprod Toxicol 4 (1990) 321-324
38. Tubiana M., Averbeck D., Bourguignon M., and Bourhis J. Radiobiologie-radiotherapie et radioprotection (2008), Hermann, Paris
39. Hall E.J., and Giaccia A.J. Radiobiology for the radiologist (2005), Lippincott Williams & Wilkins, Philadelphia, PA
40. Santin A.D., Hermonat P.L., Hiserodt J.C., Chiriva-Internati M., Woodliff J., Theus J.W., et al. Effects of irradiation on the expression of major histocompatibility complex class I antigen and adhesion costimulation molecules ICAM-1 in human cervical cancer. Int J Radiat Oncol Biol Phys 39 (1997) 737-742
41. Chiriva-Internati M., Grizzi F., Pinkston J., Morrow K.J., D'Cunha N., Frezza E.E., et al. Gamma-radiation upregulates MHC class I/II and ICAM-I molecules in multiple myeloma cell lines and primary tumors. In Vitro Cell Dev Biol Anim 2 (2006) 89-95
42. Reits E.A., Hodge J.W., Herberts C.A., Groothuis T.A., Chakraborty M., Wansley E.K., et al. Radiation modulates the peptide repertoire, enhances MHC class I expression, and induces successful antitumor immunotherapy. J Exp Med 203 (2006) 1259-1271
43. Klein B., Loven D., Lurie H., Rakowsky E., Nyska A., Levin I., et al. The effect of irradiation on expression of HLA class I antigens in human brain tumors in culture. J Neurosurg 80 (1994) 1074-1077
44. Hauser S.H., Calorini L., Wazer D.E., and Gattoni-Celli S. Radiation-enhanced expression of major histocompatibility complex class I antigen H-2Db in B16 melanoma cells. Cancer Res 53 (1993) 1952-1955
45. Liao Y.P., Wang C.C., Butterfield L.H., Economou J.S., Ribas A., Meng W.S., et al. Ionizing radiation affects human MART-1 melanoma antigen processing and presentation by dendritic cells. J Immunol 173 (2004) 2462-2469
46. Cao M.D., Chen Z.D., and Xing Y. Gamma irradiation of human dendritic cells influences proliferation and cytokine profile of T cells in autologous mixed lymphocyte reaction. Cell Biol Int 28 (2004) 223-228
47. Reuben J.M., Korbling M., Gao H., and Lee B.N. The effect of low dose gamma irradiation on the differentiation and maturation of monocyte derived dendritic cells. J Gravit Physiol 11 (2004) 49-52
48. Urosevic M., Kempf W., Zagrodnik B., Panizzon R., Burg G., and Dummer R. HLA-G expression in basal cell carcinomas of the skin recurring after radiotherapy. Clin Exp Dermatol 30 (2005) 422-425
49. Braud V.M., Allan D.S., O'Callaghan C.A., Soderstrom K., D'Andrea A., Ogg G.S., et al. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C. Nature 391 (1998) 795-799
50. Diaz-Lagares A., Alegre E., LeMaoult J., Carosella E.D., and Gonzalez A. Nitric oxide produces HLA-G nitration and induces metalloprotease-dependent shedding creating a tolerogenic milieu. Immunology 126 (2009) 436-445
51. Zhao W., Diz D.I., and Robbins M.E. Oxidative damage pathways in relation to normal tissue injury. Br J Radiol 80 (2007) S23-S31
52. Gisone P., Boveris A.D., Dubner D., Perez M.R., Robello E., and Puntarulo S. Early neuroprotective effect of nitric oxide in developing rat brain irradiated in utero. Neurotoxicology 24 (2003) 245-253
53. Gisone P., Dubner D., Del Perez R.M., Michelin S., and Puntarulo S. The role of nitric oxide in the radiation-induced effects in the developing brain. In Vivo 18 (2004) 281-292
54. Zidi I., Guillard C., Marcou C., Krawice-Radanne I., Sangrouber D., Rouas-Freiss N., et al. Increase in HLA-G1 proteolytic shedding by tumor cells: a regulatory pathway controlled by NF-kappaB inducers. Cell Mol Life Sci 63 (2006) 2669-2681
55. Hallahan D.E., Spriggs D.R., Beckett M.A., Kufe D.W., and Weichselbaum R.R. Increased tumor necrosis factor alpha mRNA after cellular exposure to ionizing radiation. Proc Natl Acad Sci USA 86 (1989) 10104-10107
56. Sherman M.L., Datta R., Hallahan D.E., Weichselbaum R.R., and Kufe D.W. Regulation of tumor necrosis factor gene expression by ionizing radiation in human myeloid leukemia cells and peripheral blood monocytes. J Clin Invest 87 (1991) 1794-1797
57. Hallahan D.E., Virudachalam S., Sherman M.L., Huberman E., Kufe D.W., and Weichselbaum R.R. Tumor necrosis factor gene expression is mediated by protein kinase C following activation by ionizing radiation. Cancer Res 51 (1991) 4565-4569
58. Contini P., Ghio M., Poggi A., Filaci G., Indiveri F., Ferrone S., et al. Soluble HLA-A,-B,-C and -G molecules induce apoptosis in T and NK CD8+ cells and inhibit cytotoxic T cell activity through CD8 ligation. Eur J Immunol 33 (2003) 125-134
59. Park G.M., Lee S., Park B., Kim E., Shin J., Cho K., et al. Soluble HLA-G generated by proteolytic shedding inhibits NK-mediated cell lysis. Biochem Biophys Res Commun 313 (2004) 606-611